Article: A PROSPECTIVE, MULTI-ARM, OPEN-LABEL CLINICAL EVALUATION OF SURABHI SAARA CAPSULES IN FIVE CHRONIC CONDITIONS

Article Category: Original Research articles

DOI: 10.7897/2277-4343.166218

Pages: 81-87

Author: B. Raghavendra Hemmanna *, Achinthya R. Hemmanna

Abstract: Background: Chronic diseases such as diabetes, varicose veins, polycystic ovarian disease (PCOD), oral ulcers, and gastrointestinal acidity significantly impact health-related quality of life and are increasingly prevalent in modern society. Surabhi Saara, a polyherbal Ayurvedic formulation, has traditionally been used for systemic detoxification and symptomatic relief. Objective: To evaluate the efficacy and safety of Surabhi Saara in a single-center, multi-arm, open-label clinical study among patients suffering from these chronic conditions. Materials and Methods: A total of 50 participants were enrolled and assigned into five arms based on their primary diagnosis. Each group received Surabhi Saara capsules (400 mg) twice daily for 240 days. Primary endpoints included random blood sugar (RBS), Venous Clinical Severity Score (VCSS), ovarian morphology, mouth ulcer characteristics, and esophageal pH. Secondary outcomes included quality-of-life (QoL) improvements and adverse event (AE) monitoring. Data were analyzed using paired t-tests and chi-square tests (p < 0.05 considered significant). Results: Statistically significant improvements were observed in all arms. In diabetes, RBS levels dropped from 190.4 to 138.3 mg/dL, with 50% achieving RBS

Keyword: Ayurveda, Diabetes, PCOD, Varicose Veins, Mouth Ulcers, Acidity, Surabhi Saara.